tiprankstipranks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Stock Investors

198 Followers
Based on 727,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold SPRY
On average, investors allocate 0.00% of their portfolios to SPRY
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 727,786 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding SPRY

0.2%
Last 7
Days
1.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding SPRY, out of 727,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

SPRY Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.85%
$10.22
Reduced
0.11%
$8.46
Based on the activity of 13,677 investors who made their portfolios public
The table shows changes in SPRY in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

SPRY Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.11%
-0.88%
-2.94%
38.32B
Consumer Cyclical
Riot Platforms
4.85%
-0.72%
+1.41%
2.31B
Financial
Merck & Company
4.12%
-0.31%
-0.70%
318.45B
Healthcare
Coherus Biosciences
2.65%
-1.56%
-8.05%
248.34M
Healthcare
Marathon Digital Holdings
5.39%
-0.11%
-3.27%
4.55B
Financial
ChargePoint Holdings
3.93%
-1.00%
-7.40%
681.61M
Consumer Cyclical
ServiceNow
4.03%
-0.56%
-0.52%
157.59B
Technology
Cisco Systems
4.55%
-0.74%
-5.17%
196.35B
Technology
Block
4.54%
-1.46%
-6.95%
47.40B
Technology
XPeng, Inc. ADR
5.23%
-1.46%
-4.66%
7.39B
Consumer Cyclical
Based on the activity of 727,786 active portfolios
Open your Smart Portfolio

SPRY Investor Analysis

SPRY investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
18.2%
of SPRY holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
SPRY investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
56.8%
of SPRY holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
SPRY investors over 55

Over 55

6.6%
Last 30 days
Holdings Change
25.0%
of SPRY holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of SPRY stock investors
See who invests in SPRY according to age group and performance.

FAQ

How many retail Investors hold SPRY?
<0.1% of TipRanks' retail investors hold SPRY in their portfolios.
    What is SPRY Investor Sentiment?
    SPRY’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of SPRY in the last 7 days?
      ▲ 0.2% of TipRanks' retail investors changed their holding of SPRY in the last 7 days.
        What percentage of retail investors changed their holding of SPRY in the last 30 days?
        ▲ 1.0% of TipRanks' retail investors changed their holding of SPRY in the last 30 days.
          What is the average age of retail investors who hold SPRY?
          The average age of SPRY Holders is between 35–55.
            What other stocks have SPRY investors also bought?
            SPRY Investors also bought DKNG, RIOT, MRK, CHRS, MARA, CHPT, NOW, CSCO, SQ, XPEV.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis